Task: Answer the multiple choice question.
Question: Which drug exhibits a -1.112\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CC1CCCCN1CCNC(=O)CCn1nc(-c2ccccc2)ccc1=O
b: O=C(NCc1ccccn1)c1nc(-c2ccc(C(F)(F)F)cc2)no1
Answer: b. O=C(NCc1ccccn1)c1nc(-c2ccc(C(F)(F)F)cc2)no1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCc1ccccn1)c1nc(-c2ccc(C(F)(F)F)cc2)no1
O=C(NCc1ccccn1)c1nc(-c2ccc(C(F)(F)F)cc2)no1
N-(pyridin-2-ylmethyl)-3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazole-5-carboxamide